Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nasdaq:cytk

POPULAR ARTICLES

NASDAQ:CYTK

pharmaceutical investing

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

pharmaceutical investing

Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-3773274

Cytokinetics and Cure SMA Renew Partnership

LATEST ARTICLES

Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy

Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274

pharmaceutical investing

Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program

Latest News

1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

Brunswick Exploration Completes Brokered Private Placement for Gross Proceeds of C$3.5 Million

Juggernaut Files for Final Approval of Oversubscribed Financing

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results